CLINICAL

The move is part of Eisai China’s goal to bolster the production efficiency and stable supply chain of...

Boehringer Ingelheim has signed a commercial supply agreement for biotechnology firm BeiGene’s tislelizumab. Tislelizumab is an investigational humanised...

The virus, which is known to cause mild cold and stomach bug symptoms in children, was found to...

The decision comes on the back of data from a Phase III trial funded and conducted by UK...

GAK is known to be utilised by the cancer cells to continue division and growth, and its blockade...

Nerlynx is a kinase inhibitor indicated for the extended adjuvant treatment of adult patients with early stage human...

DRUG

NBTXR3 is an aqueous suspension of hafnium oxide nanoparticles being developed for direct injection into cancerous tumours, and...

US-based Syapse has formed a strategic alliance with Roche to accelerate product development and clinical delivery for offering...

The partnership is set to discover and develop compounds for various undisclosed G-protein coupled receptor (GPCR) targets. It...

s part of the new structure, Sanofi will receive global development and commercialisation rights to an investigational RNAi...

The agreement involves an option for potential inclusion of the Republic of Korea in the next three years....

Both parties will work to a joint research plan with a focus on mechanisms related to inflammation, neuropharmacology...

MANUFACTURING

The deal gives Boehringer an exclusive option to purchase Autifony’s Kv3.1/3.2 positive modulator platform, and includes lead compound...

Under the deal, Horizon will develop and provide Reference Standard* material expressing neurotrophic tropomyosin receptor kinase (NTRK) fusion...

Scientists have designed a soft robotic system with artificial muscles that can assist cardiac function in children who...

In order to ensure quality drugs at affordable cost, a Pharma Park, which can manufacture at least a...

Fortis Healthcare board has approved the proposed acquisition of entire portfolio of Singapore-listed RHT Health Trust (RHT) for...

Biocon's contract research arm Syngene International has expanded its ongoing drug discovery and development with US-based Bristol-Myers Squibb...

PROJECTS & WHITEPAPERS

The pilot was launched to allow drug license holders to use qualified contract manufacturing service providers in certain...

CordenPharma has entered into definite agreements to acquire the former Hospira Boulder (Colorado) high containment API site from...

Otsuka Pharmaceutical and Lundbeck announce that patient enrollment has been initiated in two global Phase 3 clinical trials...

Flex Pharma announced that, under its open investigational new drug (IND) application, the Company has initiated a Phase...

Ortek Therapeutics announced that the Ortek ECD™ received 510(k) clearance from the U.S. Food and Drug Administration. The ECD...

US-based biopharmaceutical company Pfizer began the construction of a new research and development (R&D) laboratory and office facility...